Kura Oncology, Inc. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kura Oncology, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Kura Oncology, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $5.48M, a 41.6% increase year-over-year.
  • Kura Oncology, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $20M, a 77.5% increase year-over-year.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2023 was $13.2M, a 227% increase from 2022.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2022 was $4.03M, a 408% increase from 2021.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2021 was $792K, a 65.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.2M +$9.15M +227% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $4.03M +$3.23M +408% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $792K -$1.48M -65.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $2.27M -$2.07M -47.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $4.34M +$1.9M +78.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $2.44M +$1.79M +279% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $643K -$164K -20.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $807K -$433K -34.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 $1.24M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.